Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways

Details for Australian Patent Application No. 2010249705 (hide)

Owner CDG Therapeutics, Inc.

Inventors Beattie, Craig; Yamada, Tohru; Das Gupta, Tapas

Agent Shelston IP

Pub. Number AU-A-2010249705

PCT Pub. Number WO2010/135299

Priority 12/467,799 18.05.09 US

Filing date 18 May 2010

Wipo publication date 25 November 2010

International Classifications

C12N 5/02 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Propagation of single cells or cells in suspension

C12N 9/06 (2006.01) Enzymes, e.g. ligases (6.) - acting on nitrogen containing compounds as donors (1.4, 1.5, 1.7)

Event Publications

22 December 2011 PCT application entered the National Phase

  PCT publication WO2010/135299 Priority application(s): WO2010/135299

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010249706-Biodegradable nanofibers and implementations thereof

2010249698-Model based multi-tier authentication